000 01383 a2200409 4500
005 20250511164824.0
264 0 _c19770129
008 197701s 0 0 eng d
022 _a0306-4530
024 7 _a10.1016/0306-4530(75)90011-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSmythies, J R
245 0 0 _aMeeting report: Biochemical aspects of schizophrenia. Alabama, April 1975.
_h[electronic resource]
260 _bPsychoneuroendocrinology
_c1975
300 _a199-201 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcute Disease
650 0 4 _aBlood Platelets
_xenzymology
650 0 4 _aChronic Disease
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aFolic Acid
_xmetabolism
650 0 4 _aHallucinogens
650 0 4 _aHumans
650 0 4 _aMesencephalon
_xmetabolism
650 0 4 _aMethionine
_xtherapeutic use
650 0 4 _aMonoamine Oxidase
_xblood
650 0 4 _aProlactin
650 0 4 _aReceptors, Dopamine
_xmetabolism
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSerotonin
_xmetabolism
650 0 4 _aT-Lymphocytes
_xmetabolism
650 0 4 _agamma-Aminobutyric Acid
_xmetabolism
700 1 _aBradley, R J
700 1 _aLinton, P H
773 0 _tPsychoneuroendocrinology
_gvol. 1
_gno. 2
_gp. 199-201
856 4 0 _uhttps://doi.org/10.1016/0306-4530(75)90011-6
_zAvailable from publisher's website
999 _c1094260
_d1094260